Ruel Cedeno
Questioner · DISC type cAs Head of Cheminformatics at Novalix, Ruel leads the development of AI-driven drug design platforms. He leverages machine learning, molecular docking, and deep learning to support medicinal chemistry programs from hit identification to lead optimization. He earned his Doctor of Philosophy from Aix-Marseille University.
His methodologies have consistently ranked among the top performers in several international machine learning challenges focused on drug discovery, including those organized by Pfizer and IBM Research.
Read the full overview →How Ruel shows up
They prefer to fully evaluate every situation. They are more likely than others to negotiate on pricing and terms. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.
Topics Ruel cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other CNRS Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.